Creatinine Clearance in Obesity
Total body weight overestimates clearance: pick the right weight.
Which body weight and equation to use for creatinine clearance in obesity.
Medically reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Last reviewed October 2026.
In obesity, putting total body weight into Cockcroft-Gault overestimates creatinine clearance. Extra body weight in obesity is mostly fat, which produces little creatinine, so the formula credits the kidneys with clearance the patient does not have.
Why Total Body Weight Inflates the Estimate
Cockcroft-Gault multiplies by weight because, in an average build, weight tracks muscle mass, and muscle is what produces creatinine. In obesity that link breaks: most of the excess weight is adipose tissue, which is metabolically quiet and generates almost no creatinine. Feeding the full weight into the formula therefore rewards the kidneys for muscle that isn't there. In a study of 3,678 patients comparing Cockcroft-Gault with measured 24-hour creatinine clearance, none of the weights tested gave an unbiased estimate in overweight, obese, or morbidly obese patients. Adjusted body weight came closest. The National Kidney Foundation also notes that, as average body weight has risen, using total body weight or any single weight across the full range of body sizes reduces the accuracy of the estimate.
Which Weight to Use
The choice depends on how actual weight compares with ideal body weight (IBW). The Devine formula sets IBW at 50 kg plus 2.3 kg per inch over 5 feet for men and 45.5 kg plus 2.3 kg per inch over 5 feet for women. The rule used on this site is:
- Actual weight below IBW: use actual weight.
- Actual weight from IBW up to 130% of IBW: use ideal body weight.
- Actual weight more than 130% of IBW: use adjusted body weight, IBW + 0.4 × (actual − IBW), which adds back 40% of the excess to capture the modest extra lean tissue that comes with obesity.
This rule follows Winter and colleagues (2012). In their analysis, actual body weight was unbiased in underweight patients and ideal body weight was unbiased in patients of normal weight. Adjusted body weight with a 0.4 factor was the least biased and most accurate option in overweight, obese, and morbidly obese patients. The FDA 2024 guidance on pharmacokinetics in renal impairment agrees. In overweight or obese people, it says that ideal or adjusted body weight in Cockcroft-Gault is likely to estimate kidney function more accurately than actual body weight.
For example, a patient with an ideal weight of 60 kg who actually weighs 110 kg is at about 183% of IBW, well above the 130% cut point (78 kg). The dosing weight is therefore the adjusted body weight, 60 + 0.4 × (110 − 60) = 80 kg, not the full 110 kg.
Hospital and Protocol Rules
The cut point is a convention that varies between settings. Some hospitals switch to adjusted body weight at 120% of IBW rather than 130%, and trial protocols and drug labels can set their own weight rule, which then takes priority over both. SWOG Policy 38 is one published example. It calculates creatinine clearance with the patient's weight capped at 140% of IBW and notes that definitions of obesity have ranged from 120% to 140% of ideal body weight. Because these rules give different answers for the same patient, check which one applies before you calculate, and record it alongside the result.
What the Salazar-Corcoran Equation Adds
The Salazar-Corcoran equation was derived specifically in obese patients and folds height and weight into the formula directly, so it does not require the clinician to first decide which weight to plug in. That removes a step where errors creep in. It is most useful when obesity is marked, for instance a body mass index well above 30, and is a reasonable alternative to running Cockcroft-Gault with an adjusted weight. Whichever route is taken, the two methods should land in a similar range; a large discrepancy is a prompt to re-check the inputs.
Where Lean Body Weight Fits
Lean body weight estimates the muscle-bearing mass directly, and some drugs are dosed on it. It is not part of the Cockcroft-Gault weight rule used on this site, so use it in the equation only when a drug label or protocol names it. Whichever weight is chosen, the aim is to enter the mass that actually produces creatinine rather than the full weight on the scale. Document which weight you used, since the choice meaningfully changes the dose.
Why the Choice of Weight Changes the Dose
The weight you feed the formula flows straight through to the clearance and then to the drug dose, which is why the choice matters clinically. Cockcroft-Gault is directly proportional to weight, so in the example above, entering 110 kg instead of the 80 kg adjusted weight raises the calculated clearance by the same proportion, about 38%. For a renally cleared antibiotic or anticoagulant, a gap of that size could mean a dose that is too high and accumulates. Documenting the weight chosen makes the dose reproducible for the next clinician. When the calculated value and the patient's clinical response disagree, trust the patient and re-examine the inputs.
Calculate with the appropriate weight using the creatinine clearance calculator, and confirm renally cleared drug doses against the patient's clinical response. Where an accurate value is critical, a measured creatinine clearance or a cystatin C-based estimate can settle a doubtful case, since cystatin C does not depend on muscle mass and sidesteps the weight question altogether.